Human Papilloma Virus (HPV) Not Yet Recruiting Phase 2 Trials for Lenvatinib (DB09078)

Back to Human Papilloma Virus (HPV)

Also known as: Human Papilloma Virus / HPV Infections / HPV (Human Papillomavirus) / Human Papillomavirus (HPV) / HPV Infection / Human Papillomavirus / HPV Disease / Papilloma Virus, Human / Human Papillomavirus Infection / Human papillomavirus infection (disorder) / Human papilloma virus infection / Human Papillomavirus Viruses / Human papillomavirus (organism) / Papillomavirus Infections / Disease caused by Papillomavirus (disorder) / Papilloma viral infection / Papilloma viral infection NOS / Papilloma viral infections

Indication	Status	Phase
DBCOND0040889 (Human Papilloma Virus (HPV))	Not Yet Recruiting	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT04645602	Lenvatinib and Pembrolizumab Combination Therapy In HPV-associated Recurrent Respiratory Papilloma Patients With Laryngeal, Tracheal, and/or Pulmonary Involvement	Treatment	Lenvatinib (DB09078) Pembrolizumab (DB09037)